A case of interleukin-6-producing cardiac myxoma resembling multicentric Castleman's disease

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 2, 2009, Pages 499-501

  Morishima, Atsutomo ^a   Marui, Akira ^a   Shimamoto, Takeshi ^a   Saji, Yoshiaki ^a   Nishina, Takeshi ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

AGED; ANAMNESIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; HEART MYXOMA; HISTOPATHOLOGY; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AGED; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HEART NEOPLASMS; HUMANS; INTERLEUKIN-6; MALE; MYXOMA;

EID: 67651087314     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.05.048     Document Type: Article

References (16)

1. Mendoza C.E., Rosado M.F., and Bernal L. The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J 28 (2001) 3-7
2. Keeling I.M., Oberwalder P., Anelli-Monti M., Schuchlenz H., Demel U., Tilz G.P., et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 22 (2002) 971-977
3. Castleman B., Iverson L., and Menendez V.P. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 9 (1956) 822-830
4. Dham A., and Peterson B.A. Castleman disease. Curr Opin Hematol 14 (2007) 354-359
5. Yoshizaki K., Matsuda T., Nishimoto N., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74 (1989) 1360-1367
6. Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull 30 (2007) 2001-2006
7. Nishimoto N., Kanakura Y., Aozasa K., et al. Humanized antiinterleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106 (2005) 2627-2632
8. Akahane D., Kimura Y., Sumi M., et al. Effectiveness of long term administration of humanized antiinterleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement. Rinsho Ketsueki 47 (2006) 748-752
9. Shiraishi I., Yamagishi M., Kato R., et al. A case in a child of giant left-atrial myxoma associated with recurrent high fever and myxoma cells expressing interleukin-6. Eur J Pediatr 165 (2006) 346-347
10. Yokomuro H., Yoshihara K., Watanabe Y., Shiono N., Koyama N., and Takanashi Y. The variations in the immunologic features and interleukin-6 levels for the surgical treatment of cardiac myxomas. Surg Today 37 (2007) 750-753
11. Mendoza C.E., Rosado M.F., and Pacheco P. Interleukin-6 production and recurrent cardiac myxoma. J Thorac Cardiovasc Surg 121 (2001) 395-396
12. Yaguchi H., Murakami Y., Sengoku R., Sato H., and Inoue K. A case of cardiac myxoma presenting with multiple cerebellar hemorrhages and elevation of interleukin-6 in the cerebrospinal fluid. Rinsho Shinkeigaku 44 (2004) 677-681 [in Japanese]
13. Amano J., Kono T., Wada Y., et al. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg 9 (2003) 215-221
14. Nishio Y., Ito Y., Iguchi Y., and Sato H. MPO-ANCA-associated pseudovasculitis in cardiac myxoma. Eur J Neurol 12 (2005) 619-620
15. Takizawa T., Sumino H., Kanda T., Kobayashi I., Nagai R., and Ichikawa S. An interleukin-6-producing cardiac myxoma associated with mediastinal lymphadenopathy. Cardiology 92 (1999) 275-277
16. Kanda T., and Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J 45 (2004) 183-193